section name header

Y-Site Injection Compatibility (1:1 Mixture)

Ciprofloxacin

(Mfr: FRK)(Conc: 2 mg/mL)

I

Blinatumomab

(Mfr: AMG)(Conc: 0.125 and 0.375 mcg/mLb)

Remarks:

Persistent particulate formation

Ref:

3405,3417